Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Outlook Therapeutics Inc
(NQ:
OTLK
)
5.040
-0.090 (-1.75%)
Streaming Delayed Price
Updated: 12:32 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Outlook Therapeutics Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
October 03, 2024
Via
Benzinga
OTLK Stock Earnings: Outlook Therapeutics Beats EPS for Q3 2024
August 14, 2024
OTLK stock results show that Outlook Therapeutics beat analyst estimates for earnings per share the third quarter of 2024.
Via
InvestorPlace
3 Undervalued Gems Set to Soar 1,000% by 2026
June 25, 2024
Discover the fundamentals behind three undervalued stocks to buy in the oil and gas, advertising, and biotechnology industries.
Via
InvestorPlace
OTLK Stock Earnings: Outlook Therapeutics Misses EPS for Q2 2024
May 15, 2024
OTLK stock results show that Outlook Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Biotech on a Budget: 7 Stocks Under $10 With Huge Potential
April 15, 2024
With the medical care industry always liable for negative surprises, you might as well go for big upside with under-$10 biotech stocks.
Via
InvestorPlace
Analyst Ratings for Outlook Therapeutics
November 03, 2023
Via
Benzinga
Insiders Buying Outlook Therapeutics And 2 Other Stocks
April 01, 2024
Although U.S. stocks closed mixed on Thursday, there were a few notable insider trades.
Via
Benzinga
Gold Moves Lower; Lululemon Shares Plummet
March 22, 2024
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 0.3% on Friday. The Dow traded down 0.49% to 39,585.67 while the NASDAQ rose 0.26% to 16,444.91. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 22, 2024
Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 22, 2024
Via
Benzinga
Dow Dips 200 Points; Nike Shares Fall After Q3 Results
March 22, 2024
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points. The Dow traded down 0.54% to 39,565.50 while the NASDAQ rose 0.04% to 16,408.74. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Higher On Friday?
March 22, 2024
Outlook Therapeutics stock sees uptick as European Medicines Agency committee issues positive opinion on ONS-5010/LYTENAVA for wet age-related macular degeneration (wet AMD). Strong trading volume...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 22, 2024
Via
Benzinga
Over $1.7M Bet On Globalstar? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
March 12, 2024
The Dow Jones index closed higher by around 47 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
7 of the Best Speculative Stocks You Can Snag for Less Than $1
March 06, 2024
Although speculative stocks under $1 are by their very nature extremely risky, these ideas might have enough to go the distance.
Via
InvestorPlace
7 Biotech Penny Stocks on the Verge of Clinical Trial Victory
February 25, 2024
Biotech penny stocks represent one heckuva risk. However, if the stars align, you could be talking some serious money.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
February 22, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 23, 2024
Via
Benzinga
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
December 29, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
OTLK Stock Earnings: Outlook Therapeutics Reported Results for Q4 2023
December 27, 2023
Outlook Therapeutics just reported results for the fourth quarter of 2023.
Via
InvestorPlace
This Analyst Upgrades Vision Disorder-Focused Outlook Therapeutics' Prospects After FDA Agreement Despite Investor Concerns
November 03, 2023
Thursday, Outlook Therapeutics Inc (NASDAQ: OTLK) announced it completed the requested Type A Meetings with the FDA to discuss the
Via
Benzinga
Exposures
Product Safety
Cyberark Software To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday
November 03, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Crude Oil Gains Over 2%; S&P Global Raises Profit Outlook
November 02, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Thursday. The Dow traded up 1.51% to 33,775.43 while the NASDAQ rose 1.71% to 13,284.72....
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 02, 2023
Gainers OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 02, 2023
Via
Benzinga
Why Is Retinal Disease-Focused Outlook Therapeutics Stock Plunging Today?
November 02, 2023
Outlook Therapeutics Inc (NASDAQ: OTLK) shares are slumping after the company announced that it has
Via
Benzinga
Dow Jumps 400 Points; Starbucks Posts Upbeat Earnings
November 02, 2023
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 400 points on Thursday. The Dow traded up 1.21% to 33,675.91 while the NASDAQ rose 1.46% to 13,251.90. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Nasdaq Surges Over 1%; US Initial Jobless Claims Increase To 217,000
November 02, 2023
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Thursday. Following the market opening Thursday, the Dow traded up 0.82% to 33,548.07 while the NASDAQ...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 02, 2023
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.